|
Market Cap (2-Nov) $97,936,224 (648th) |
Close (30-Jun) $0.90 |
Volume (30-Jun) 134,901 |
Shortsold (27-Oct) 2,263,673 (0.27%) (386th) |
|
52w High $1.23 |
52w Low $0.120 |
P/E - |
EPS -0.19 |
[ARTICLE] ‘Next Cochlear’ stock surges after heart device breakthrough
A news article has been posted about EBR Systems on the AFR. The article was published around , on 22 May 2023 at 1:13pm.
Shares in ASX-listed EBR Systems are up nearly 10 per cent following a successful trial of its tiny cardiovascular device, which could pave the way for US FDA approval.
Read ArticleEBR was $0.91 at the close of trade on 19 May 2023
| Recent Articles about ASX:EBR | |
|---|---|
| 14-Apr | ‘Could be next Cochlear or ResMed’: heart device maker wins FDA approval
afr.com |
| 27-Dec | EBR Systems Announces 2025 Investor Roadshow in Australia
nasdaq.com |
| 27-Dec | EBR Systems Announces 2025 Investor Roadshow in Australia
markets.businessinsider.com |
| 23-Dec | EBR Systems Advances Towards 2025 U.S. Launch
nasdaq.com |
| 23-Dec | EBR Systems Advances Towards 2025 U.S. Launch
markets.businessinsider.com |
| 22-Dec | Ebr Systems Inc DRC
investing.com |
| 20-Dec | FDA pre-approval inspection of EBR’s WiSE CRT system set for early January
msn.com |
| 19-Dec | Heartbeats, no strings attached: EBR's big step toward FDA approval
finnewsnetwork.com.au |
| 19-Dec | Why Champion Iron, EBR Systems, Mesoblast, and Patriot Battery Metals shares are surging today
msn.com |
| 19-Dec | EBR Systems advances toward FDA approval with pre-approval inspection
grafa.com |
| Tracked |
Find all articles about EBR Systems, including others on the AFR, on the media page.
If you were already registered, log in here.